Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Stockholders' Equity (Unaudited)

v3.22.2
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)
Total
Common Stock
Additional Paid-in-capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 26, 2020 90,935,000        
Beginning balance at Dec. 26, 2020 $ 364,587,000 $ 9,000 $ 565,815,000 $ (171,849,000) $ (29,388,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (8,970,000)     (8,970,000)  
Stock option activity, stock awards and employee stock purchase plan 3,384,000   3,384,000    
Change in cumulative foreign currency translation adjustment  $ 2,473,000       2,473,000
Ending balance (in shares) at Mar. 27, 2021 91,203,000        
Ending balance at Mar. 27, 2021 $ 361,474,000 9,000 569,199,000 (180,819,000) (26,915,000)
Beginning balance (in shares) at Dec. 26, 2020 90,935,000        
Beginning balance at Dec. 26, 2020 $ 364,587,000 9,000 565,815,000 (171,849,000) (29,388,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (12,355,000)        
Hedging activity 0        
Change in cumulative foreign currency translation adjustment  $ 6,315,000        
Ending balance (in shares) at Jun. 26, 2021 91,221,000        
Ending balance at Jun. 26, 2021 $ 363,845,000 9,000 571,113,000 (184,204,000) (23,073,000)
Beginning balance (in shares) at Mar. 27, 2021 91,203,000        
Beginning balance at Mar. 27, 2021 $ 361,474,000 9,000 569,199,000 (180,819,000) (26,915,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (3,385,000)     (3,385,000)  
Stock option activity, stock awards and employee stock purchase plan 1,914,000   1,914,000    
Hedging activity 0        
Change in cumulative foreign currency translation adjustment  $ 3,842,000       3,842,000
Ending balance (in shares) at Jun. 26, 2021 91,221,000        
Ending balance at Jun. 26, 2021 $ 363,845,000 $ 9,000 571,113,000 (184,204,000) (23,073,000)
Beginning balance (in shares) at Dec. 25, 2021 193,995,320 193,995,000      
Beginning balance at Dec. 25, 2021 $ 1,150,095,000 $ 20,000 1,387,410,000 (210,181,000) (27,154,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (1,887,000)     (1,887,000)  
Stock option activity, stock awards and employee stock purchase plan 6,018,000   6,018,000    
Hedging activity 8,413,000        
Change in cumulative foreign currency translation adjustment  3,735,000       3,735,000
Ending balance (in shares) at Mar. 26, 2022   194,048,000      
Ending balance at Mar. 26, 2022 $ 1,166,374,000 $ 20,000 1,393,428,000 (212,068,000) (15,006,000)
Beginning balance (in shares) at Dec. 25, 2021 193,995,320 193,995,000      
Beginning balance at Dec. 25, 2021 $ 1,150,095,000 $ 20,000 1,387,410,000 (210,181,000) (27,154,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 6,929,000        
Hedging activity 11,522,000        
Change in cumulative foreign currency translation adjustment  $ (911,000)        
Ending balance (in shares) at Jun. 25, 2022 194,270,779 194,271,000      
Ending balance at Jun. 25, 2022 $ 1,177,088,000 $ 20,000 1,396,863,000 (203,252,000) (16,543,000)
Beginning balance (in shares) at Mar. 26, 2022   194,048,000      
Beginning balance at Mar. 26, 2022 1,166,374,000 $ 20,000 1,393,428,000 (212,068,000) (15,006,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 8,816,000     8,816,000  
Stock option activity, stock awards and employee stock purchase plan 3,435,000   3,435,000    
Hedging activity 3,109,000        
Change in cumulative foreign currency translation adjustment  $ (4,646,000)       (4,646,000)
Ending balance (in shares) at Jun. 25, 2022 194,270,779 194,271,000      
Ending balance at Jun. 25, 2022 $ 1,177,088,000 $ 20,000 $ 1,396,863,000 $ (203,252,000) $ (16,543,000)